colon cancer

Seven diseases benefiting from genetic tests
Seven diseases benefiting from genetic testsGenetic testing is playing a growing role in diagnosing and treating diseases, particularly when it comes to certain cancers and rheumatic conditions.
Genetic tests guide cancer therapy, improve efficacyAt the ASCO 2016 Annual Meeting, an expert from the Moffitt Cancer Center will discuss use of genetics to guide targeted-therapies and immunotherapies.
FDA approves Cyramza for treatment of metastatic colorectal cancerFDA has approved Cyramza (ramucirumab, Eli Lilly) injection for the treatment of metastatic colorectal cancer with disease progression on or after prior therapy.
Are women with PCOS at greater risk of cancer?According to a new study in Gynecologic Oncology, women who have polycystic ovary syndrome (PCOS) may be at greater risk of developing some types of cancer.
Common osteoporosis drugs may prevent breast, lung, colon cancersBisphosphonates, the most commonly used drugs for osteoporosis may be able to reduce the growth of certain cancers by inhibiting the activity of a cancer-producing family of receptor called the human epidermal growth factor receptor (HER), according to 2 studies published online this week in the Proceedings of the National Academy of Sciences (PNAS).
Breast, colon cancer rare but aggressive in kidsBreast and colorectal cancers, although rare in children, are also more aggressive than in adults, according to 2 studies based on patient records from the National Cancer Data Base that were presented at the recent Clinical Congress of the American College of Surgeons.
Engagement drives utilization of preventive servicesHealth plans are supporting providers by offering outcomes-driven engagement programs for members
Colonoscopy remains high value preventive carePlan's data show 1.2% of screenings resulted in cancer diagnosis
Colon cancer screening doubles with new EHR useCentralized systems are likely to be the most efficient way to increase colorectal cancer screening, according to a trial published in the March 5 Annals of Internal Medicine.